60 - Special Session - The Fascinating Intersection of Genetics, Color Vision, & Modern Myopia Management

Disclosure(s):

Chris Wroten, OD: Alcon: Consulting Fees ()

Jay Neitz, PhD: No financial relationships to disclose

Ashley D. Wallace-Tucker, OD, FAAO, FSLS: Bausch + Lomb: Consulting Fees (); CooperVision: Consulting Fees (); Topcon: Consulting Fees (); Visionary Optics: Consulting Fees ()

Shane R. Kannarr, OD: AbbVie/Allergan: Advisory Committee/Board Member (), Consulting Fees (), Independent Contractor (including contracted research) (); Alcon: Advisory Committee/Board Member (), Consulting Fees (), Independent Contractor (including contracted research) (); Bausch + Lomb: Advisory Committee/Board Member (), Consulting Fees (), Independent Contractor (including contracted research) (), Speaker's Bureau (honoraria or other compensation) (); CooperVision: Independent Contractor (including contracted research) (); Essilor: Advisory Committee/Board Member (), Independent Contractor (including contracted research) (); Johnson & Johnson Vision: Advisory Committee/Board Member (), Consulting Fees (), Independent Contractor (including contracted research) (), Speaker's Bureau (honoraria or other compensation) (); LENZ: Advisory Committee/Board Member (), Consulting Fees (), Independent Contractor (including contracted research) (); Ocuphire: Independent Contractor (including contracted research) (); Sight Sciences: Consulting Fees (), Researcher (grant funding or other support) (); Sydnexis: Consulting Fees (), Independent Contractor (including contracted research) (); Tarsus Pharma: Advisory Committee/Board Member (), Consulting Fees (), Independent Contractor (including contracted research) (), Speaker's Bureau (honoraria or other compensation) (); Tenpoint: Advisory Committee/Board Member (); Topcon: Advisory Committee/Board Member (), Consulting Fees (), Researcher (grant funding or other support) (); Visus Therapeutics: Independent Contractor (including contracted research) ()